Your browser doesn't support javascript.
loading
In vivo evaluation of the EZH2 inhibitor (EPZ011989) alone or in combination with standard of care cytotoxic agents against pediatric malignant rhabdoid tumor preclinical models-A report from the Pediatric Preclinical Testing Consortium.
Kurmasheva, Raushan T; Erickson, Stephen W; Earley, Eric; Smith, Malcolm A; Houghton, Peter J.
  • Kurmasheva RT; Department of Molecular Medicine, Greehey Children's Cancer Research Institute, San Antonio, Texas.
  • Erickson SW; RTI International, Research Triangle Park, North Carolina.
  • Earley E; RTI International, Research Triangle Park, North Carolina.
  • Smith MA; National Cancer Institute, Bethesda, Maryland.
  • Houghton PJ; Department of Molecular Medicine, Greehey Children's Cancer Research Institute, San Antonio, Texas.
Pediatr Blood Cancer ; 68(2): e28772, 2021 02.
Article en En | MEDLINE | ID: mdl-33089597
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Rabdomiosarcoma / Proteína Potenciadora del Homólogo Zeste 2 / Antineoplásicos Límite: Animals / Female / Humans Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Rabdomiosarcoma / Proteína Potenciadora del Homólogo Zeste 2 / Antineoplásicos Límite: Animals / Female / Humans Idioma: En Año: 2021 Tipo del documento: Article